CompletedPhase 2NCT04676737

TTHX1114(NM141) in Combination With DWEK/DSO

Studying Corneal dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Trefoil Therapeutics, Inc.
Principal Investigator
Thomas Tremblay
Trefoil Therapeutics.com
Intervention
TTHX1114(NM141)(drug)
Enrollment
49 enrolled
Eligibility
18 years · All sexes
Timeline
20212023

Study locations (11)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04676737 on ClinicalTrials.gov

Other trials for Corneal dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Corneal dystrophy

← Back to all trials